0001209191-21-054799.txt : 20210903 0001209191-21-054799.hdr.sgml : 20210903 20210903170016 ACCESSION NUMBER: 0001209191-21-054799 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210901 FILED AS OF DATE: 20210903 DATE AS OF CHANGE: 20210903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burgess Justin CENTRAL INDEX KEY: 0001812025 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34207 FILM NUMBER: 211237232 MAIL ADDRESS: STREET 1: C/O DYNAVAX TECHNOLOGIES CORPORATION STREET 2: 2100 POWELL STREET, SUITE 1900 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001029142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330728374 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 POWELL STREET STREET 2: SUITE 900 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 5108485100 MAIL ADDRESS: STREET 1: 2100 POWELL STREET STREET 2: SUITE 900 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-09-01 0 0001029142 DYNAVAX TECHNOLOGIES CORP DVAX 0001812025 Burgess Justin C/O DYNAVAX TECHNOLOGIES 2100 POWELL STREET, SUITE 900 EMERYVILLE CA 94608 0 1 0 0 Principal Accounting Officer Common Stock 2021-09-01 4 M 0 20000 3.81 A 23721 D Common Stock 2021-09-01 4 S 0 20000 20.00 D 3721 D Stock Option (Right to Buy) 3.81 2021-09-01 4 M 0 20000 D 2026-06-13 Common Stock 20000 0 D The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2021. All shares were sold at $20.00. All of the shares subject to the option vested and become fully-exercisable on August 13, 2020. Not applicable. /s/ Justin Burgess 2021-09-03